Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance

J Korean Med Sci. 2008 Jun;23(3):556-9. doi: 10.3346/jkms.2008.23.3.556.

Abstract

Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention. We report a case of VLST of a sirolimus-eluting Cypher stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction at 26 months after deployment with continued combined dual antiplatelet medication of aspirin and clopidogrel. The patient did not show anti-platelet resistance.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angina Pectoris / therapy*
  • Aspirin / therapeutic use*
  • Clopidogrel
  • Coronary Angiography
  • Coronary Thrombosis / diagnostic imaging
  • Coronary Thrombosis / drug therapy
  • Coronary Thrombosis / etiology*
  • Drug Resistance
  • Drug-Eluting Stents / adverse effects*
  • Electrocardiography
  • Female
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Time Factors

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin